Psychedelics Blog Posts

• Using the highs to combat the lows: ketamine-assisted therapy for anxiety and depression

  20 Oct 2023

  • Gabrielle Williams

  
• Psilocybin for ‘treatment-resistant depression’: an island of hope in an ocean of uncertainty?

  12 Jul 2023

  • UCL Psychiatry MSc

  
• Psychedelics-assisted psychotherapy for alcohol use disorder: room for more evidence

  15 May 2023

  • Heidi Stevens

  
• Ketamine and suicidal ideation: French trial finds modest short-term effects

  01 Feb 2023

  • Anya Borissova

  
• How could MDMA-assisted and psilocybin-assisted psychotherapy help people with depression and PTSD?

  04 Nov 2022

  • Anya Borissova
  • and Philip Brooks

  
• Ketamine “shows promise” as an anti-suicidal ideation agent, but will this promise ever be realised?

  23 Feb 2022

  • Rosalind McAlpine
  • and Karel Kieslich

  
• Can ketamine metabolites and gamma power help predict clinical response for ‘treatment resistant depression’?

  17 Aug 2021

  • Anya Borissova

  
• Turn on, or tune out? Is psilocybin assisted therapy close to becoming a first-line treatment for depression?

  03 Jul 2021

  • James Rucker
  • and Sameer Jauhar

  
• Patients’ experience of ketamine treatment for depression: the ‘Ketamine and me’ project

  28 May 2021

  • Harmony Jiang

  
• MDMA-assisted psychotherapy for alcohol use disorder: is it feasible?

  29 Apr 2021

  • Anya Borissova